Roche’s $7.6 Billion Drug Just Hit a Wall—Here’s Why That MattersRoche's Ocrevus, a leading MS treatment, showed no added benefits at higher doses in trials, impacting future sales projections.
Pill Myth Busted: Tablets May Outpace Soft Gels in Speed and ValueA pharmacist disputes the claim that soft gel capsules act faster than tablets, revealing tablets may dissolve and absorb quicker.
120 Lives Lost to Toxic Red Yeast Rice Supplements in JapanA preliminary conclusion has emerged regarding the Japanese red yeast rice incident, in which 120 people died after consuming it.
U.S. and Allies to Discuss High-Tech Bio Collaboration and Chinese CompetitionHigh-ranking officials from South Korea, the United States, Japan, and India are set to convene at BIO USA 2024 to discuss strategies for advancing the industry. The summit will mainly address critical issues such as strengthening pharmaceutical supply chains but it may also touch upon the U.S.’s efforts to counter the influence of Chinese biotech […]
Heart Health and Weight Loss? Wegovy Does Both!A study has shown that patients who took the obesity treatment drug Wegovy maintained an average weight loss of about 10% four years later. The research results were published in the European Congress on Obesity in Venice, Italy. Wegovy is a GLP-1 receptor agonist that was the first of its kind to be released, originally […]
U.S. Tariff Hike on Chinese Goods Could Reshape Medical Industry in South KoreaImage Today With the Biden administration pushing for a tariff increase on Chinese medical devices such as syringes, needles, rubber gloves, and face masks, South Korean companies, which have struggled to secure market share due to low-cost competition, are expected to benefit from the situation. However, the pharmaceutical and biotech industries remain nervous, warning that […]
Must-Reads
1
Shaw Prize winner Baumeister on breakthroughs that changed cell imaging
LATEST
2
Coach-athlete interaction at marathon finish sparks online debate
LATEST
3
Seoul shares snap 2-day drop on hopes for rate cut, eased AI fear; won rebounds
LATEST
4
Hanwha revamps US investment arm for defense push
LATEST
5
S. Korea asks Lone Star to reimburse legal costs after winning annulment in investor dispute
Roche’s $7.6 Billion Drug Just Hit a Wall—Here’s Why That Matters Roche's Ocrevus, a leading MS treatment, showed no added benefits at higher doses in trials, impacting future sales projections.
Pill Myth Busted: Tablets May Outpace Soft Gels in Speed and Value A pharmacist disputes the claim that soft gel capsules act faster than tablets, revealing tablets may dissolve and absorb quicker.
120 Lives Lost to Toxic Red Yeast Rice Supplements in Japan A preliminary conclusion has emerged regarding the Japanese red yeast rice incident, in which 120 people died after consuming it.
U.S. and Allies to Discuss High-Tech Bio Collaboration and Chinese Competition High-ranking officials from South Korea, the United States, Japan, and India are set to convene at BIO USA 2024 to discuss strategies for advancing the industry. The summit will mainly address critical issues such as strengthening pharmaceutical supply chains but it may also touch upon the U.S.’s efforts to counter the influence of Chinese biotech […]
Heart Health and Weight Loss? Wegovy Does Both! A study has shown that patients who took the obesity treatment drug Wegovy maintained an average weight loss of about 10% four years later. The research results were published in the European Congress on Obesity in Venice, Italy. Wegovy is a GLP-1 receptor agonist that was the first of its kind to be released, originally […]
U.S. Tariff Hike on Chinese Goods Could Reshape Medical Industry in South Korea Image Today With the Biden administration pushing for a tariff increase on Chinese medical devices such as syringes, needles, rubber gloves, and face masks, South Korean companies, which have struggled to secure market share due to low-cost competition, are expected to benefit from the situation. However, the pharmaceutical and biotech industries remain nervous, warning that […]
Hot Topics